Skip to content
Research Article Open access CC BY 4.0

Comparison of In-vitro Activity of Cefixime to Doxycycline and Minocycline Against Gram-Negative Bacteria Isolated from Patients Suffering from Respiratory Tract Infections at a Tertiary Care Centre in Northern India

Akanksha Dubey, Mitra Kar, Chinmoy Sahu

Journal of Advances in Microbiology · pp. 18–26 · Published 25 Aug 2023

10.9734/jamb/2023/v23i9748

Abstract

Background: Respiratory tract infections (RTI) form a major part of common ailments encountered by a general physicians hailing from a developing country. Antibiotics are used for treating any infection but inappropriate use of antibiotics lead to development of multidrug resistance (MDR). This study was performed to analyze the comparative in-vitro activity of Cefixime and Tetracyclines by antibiotic susceptibility testing (AST) against the pathogens isolated from respiratory samples. Materials and Methods: We performed a prospective study in the Bacteriology section of the Department of Microbiology at a teaching hospital in Northern India from Jan 2022 to June 2022. Cefixime, Doxycycline, and Minocycline were tested for susceptibility against 100 Gram-negative bacteria from respiratory samples. The antibiotic susceptibility testing for each of the isolates was performed by the Kirby Bauer Disc Diffusion method, according to the CLSI, 2019 guidelines. Results: Our study cohort included 100 Gram negative isolates with a majority of them obtained from Endotracheal aspirate samples (43, 43%) followed by Sputum (37, 37%) samples. The most common microorganism tested for susceptibility to this drug was Klebsiella pneumoniae (39, 39%) followed by Escherichia coli (33, 33%). Escherichia coli was identified as the most isolated to all the antibiotics and was 12.12% (4/33, 12.12%) susceptible to all three drugs. On overall analysis activity of Doxycycline was better than Cefixime among inducible Enterobacteriaceae and non-fermenter isolate.     Conclusion: Doxycycline is a proficient antimicrobial agent for treating an array of Gram-negative bacteria-associated infections showing better in-vitro activity in comparison to Minocycline and other bactericidal agents like Cefixime.

Respiratory Tract Infection (RTI) cefixime tetracycline gram-negative bacteria MALDI-TOF-MS

References (22)

  1. 1 Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults [DOI]
  2. 2 Clinical and Laboratory Standards Institute [DOI]
  3. 3 Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance [DOI]
  4. 4 Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America [DOI]
  5. 5 MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS [DOI]
  6. 6 Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent [DOI]
  7. 7 Antimicrobial Resistance in the 21st Century: A Multifaceted Challenge [DOI]
  8. 8 Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections [DOI]
  9. 9 Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations [DOI]
  10. 10 Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class [DOI]
  11. 11 Current Trend of Antibiotic Resistance in Lower Respiratory Tract Infections (LRTIs): An Experience in a Teaching Hospital in Bangladesh [DOI]
  12. 12 Comparative study of cefixime and tetracycline as an evaluation policy driven by the antibiotic resistance crisis in Indonesia [DOI]
  13. 13 Gram-negative multidrug-resistant organisms were dominant in neurorehabilitation ward patients in a general hospital in southwest China [DOI]
  14. 14 Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection [DOI]
  15. 15 Changing trend of antimicrobial resistance among pathogens isolated from lower respiratory tract at a university-affiliated hospital of China, 2006-2010. [DOI]
  16. 16 Characteristics of Bacterial Colonization and Urinary Tract Infection after Indwelling of Double-J ureteral Stent and Percutaneous Nephrostomy Tube [DOI]
  17. 17 Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines [DOI]
  18. 18 ANTIMICROBIAL-RESISTANT PATHOGENS IN THE 1990s [DOI]
  19. 19 COMPARATIVE EFFICACY AND SAFETY OF CEFIXIME AND CIPROFLOXACIN IN THE MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN IBADAN, NIGERIA.
  20. 20 Cefixime in the Treatment of Upper Respiratory Tract Infections and Otitis media [DOI]
  21. 21 In-vitro Activity of Isepamicin against Gram-negative Bacteria in Comparison to Other Aminoglycosides Routinely used at a Teaching Hospital in Northern India [DOI]
  22. 22 Antibiotics for acute bronchitis [DOI]

Cited by 2

Assessing the Structural, Antibacterial, and Dissolution Properties of 1:1 Doxycycline/β-Cyclodextrin Complexes

J.C Shwetha, K. Pruthviraj, T. B. Rao · Journal of Molecular Structure · 2024

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

42

Page views

0

PDF downloads

7

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.